Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Ace Vision Group Announces Initial Close of $29.4 Million Series B Financing Round
-
Dyne Therapeutics Receives European Medicines Agency (EMA) Orphan Drug Designation for DYNE-251 in Duchenne Muscular Dystrophy
-
Serve Robotics to Report First Quarter 2025 Financial Results, Host Conference Call and Webcast on May 8
-
MACOM to Report Second Quarter 2025 Financial Results on May 8, 2025
-
Axi Delivers Unbeatably Tight Spreads on Key Markets Including Gold, Crypto, and Forex
-
ParaZero Achieves Extended Class C5 Certification for DJI Mavic 3 Series, Expanding European Market Access
-
CRB Appoints Ken Olson as Chief Financial Officer
-
Manhattan Bridge Capital, Inc. Reports First Quarter Results for 2025
-
The Joint Corp. to Host Conference Call on Thursday, May 8th to Discuss First Quarter 2025 Results
-
Pasithea Therapeutics to Present Updated Data from Ongoing Phase 1 Trial of PAS-004 in Advanced Cancer Patients at the 2025 ASCO Annual Meeting
-
Gilat to Report First Quarter 2025 Results on Monday, May 19th
-
Nasdaq Announces 13% Increase in Quarterly Dividend to $0.27 Per Share
-
Valley National Bancorp Announces First Quarter 2025 Results
-
Šiaulių Bankas Invitation to Q1 2025 Financial Results webinar
-
Marex Group Plc to Announce First Quarter 2025 Earnings on May 15, 2025
-
JPMorgan Announces Cash Distributions for the JPMorgan ETFs
-
Sable Sells Third Party Royalties and Grants Royalty to Osisko Gold Royalties
-
Pool Corporation Reports First Quarter Results and Confirms Annual Earnings Guidance Range
-
Matador Technologies Announces Investor Relations and Marketing Partnerships
-
First Northwest Bancorp Reports First Quarter 2025 Improved Profitability
-
Stallion Uranium Closes $1.45 million Private Placement
-
Nuwellis Expands IP Portfolio with Patent That Reduces Clinical Burden, Preserves Precision
-
Kymera Therapeutics to Unveil New Oral Immunology Program and Report First Quarter 2025 Financial Results on May 9, 2025
-
Ligand to Report First Quarter 2025 Financial Results on May 8, 2025
-
EUDA Partners with Authorized Distributor of Guangdong Cell Biotech to Offer Stem Cell Therapies to Customers in Singapore and Malaysia
-
Towards the Light: Co-creating a New Global Journey in the AI Field — The Grand 2025 AI Intelligent Development Summit
-
Nasdaq and AWS Unlock New Era of Growth for Global Capital Markets with Next Generation Infrastructure Solutions
-
Standard BioTools Announces New Product Innovations in Plasma and Single-Cell Proteomics at AACR 2025
-
YXT.com Filed 2024 Annual Report on Form 20-F
-
Aether Holdings Launches Alpha Edge Media™ to Expand its Financial Newsletters and Subscribers
-
Nasdaq Reports First Quarter 2025 Results; Diversified Business Model Driving Broad-Based Revenue Growth
-
Enthusiast Gaming’s Luminosity Crowns Three New Creators in Record-Breaking Rising Stars Campaign
-
Brunswick Exploration Drills 36 Meters at 1.51% and Continues to Extend the Mineralized Footprint of Mirage
-
Terrapin Beer Co. Celebrates 23 Years of Craft Beer and Environmental Stewardship with Terraprint Initiative and Orvis Partnership
-
Interpublic Announces First Quarter 2025 Results
-
Balchem Corporation Reports First Quarter 2025 Financial Results
-
American Airlines Reports First-Quarter 2025 Financial Results
-
ConnectOne Bancorp, Inc. Reports First Quarter 2025 Results; Declares Common and Preferred Dividends
-
PROCEPT BioRobotics Reports First Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
-
FUTURE OF LENDING TAKES CENTER STAGE: ORIGENCE ANNOUNCES POWERFUL BREAKOUT SESSION LINEUP FOR LENDING TECH LIVE ‘25
-
Marquette National Corporation Declares a Dividend of $0.31 per Share
-
Quantum BioPharma to Host Business Update Conference Call on Tuesday, May 6, 2025 at 4:30 p.m. Eastern Time
-
Hotel Equities Strengthens Presence in Caribbean and Latin America; Appoints Industry Veteran Marilia Pergola VP of Operations for the Region
-
Axonius Appoints Robert Skinner (USAF Retired) to Axonius Federal Systems Board
-
RESOLUTIONS OF THE ANNUAL GENERAL MEETING OF TULIKIVI CORPORATION
-
OP Corporate Bank plc to redeem its EUR 1,000,000,000 Resettable Callable Tier 2 Instruments due June 2030
-
OP Corporate Bank plc to redeem its SEK 3,250,000,000 Callable Floating Rate Tier 2 Instruments due June 2030
-
iSTAR Medical’s MINIject® demonstrates significant sustained 5-year efficacy in treating glaucoma in STAR-GLOBAL trial
-
EDAP To Launch New Focal One® i Robotic HIFU system at the Upcoming 120th American Urological Association (AUA) Annual Meeting
-
ADT Reports First Quarter 2025 Results

